BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Djansugurova LB, Perfilyeva AV, Zhunusova GS, Djantaeva KB, Iksan OA, Khussainova EM. The determination of genetic markers of age-related cancer pathologies in populations from Kazakhstan. Front Genet. 2013;4:70. [PMID: 23675381 DOI: 10.3389/fgene.2013.00070] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Zeng X, Zhang Y, Yue T, Zhang T, Wang J, Xue Y, An R. Association between XRCC1 polymorphisms and the risk of cervical cancer: a meta-analysis based on 4895 subjects. Oncotarget 2017;8:2249-60. [PMID: 27903984 DOI: 10.18632/oncotarget.13663] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
2 Papanagnou P, Baltopoulos P, Tsironi M. Marketed nonsteroidal anti-inflammatory agents, antihypertensives, and human immunodeficiency virus protease inhibitors: as-yet-unused weapons of the oncologists' arsenal. Ther Clin Risk Manag 2015;11:807-19. [PMID: 26056460 DOI: 10.2147/TCRM.S82049] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
3 He F, Liu C, Zhang R, Hao Z, Li Y, Zhang N, Zheng L. Association between the Glutathione-S-transferase T1 null genotype and esophageal cancer susceptibility: a meta-analysis involving 11,163 subjects. Oncotarget 2018;9:15111-21. [PMID: 29599931 DOI: 10.18632/oncotarget.24534] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
4 Karimi-zarchi M, Moghimi M, Abbasi H, Hadadan A, Tabatabaei R, Javaheri A, Neamatzadeh H. Association of XRCC3 18067 C>T (Thr241Met) polymorphism with risk of cervical and ovarian cancers: A systematic review and meta-analysis. IMAS 2020;11:172-81. [DOI: 10.1556/1646.11.2019.21] [Reference Citation Analysis]
5 Mei J, Duan H, Wang L, Yang S, Lu J, Shi T, Zhao Y. XRCC1 polymorphisms and cervical cancer risk: an updated meta-analysis. Tumor Biol 2014;35:1221-31. [DOI: 10.1007/s13277-013-1163-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
6 Yu X, Wang Q, He G, Yu H. Association between XRCC3 Thr241Met polymorphism and risk of gynecological malignancies: A meta-analysis. Cancer Genet 2021;254-255:11-7. [PMID: 33515810 DOI: 10.1016/j.cancergen.2021.01.003] [Reference Citation Analysis]
7 Zhang XQ, Li L. A meta-analysis of XRCC1 single nucleotide polymorphism and susceptibility to gynecological malignancies. Medicine (Baltimore) 2021;100:e28030. [PMID: 34918657 DOI: 10.1097/MD.0000000000028030] [Reference Citation Analysis]
8 Lu QJ, Bo YC, Zhao Y, Zhao EJ, Sapa WB, Yao MJ, Duan DD, Zhu YW, Lu WQ, Yuan L. Glutathione S-transferase M1 polymorphism and esophageal cancer risk: An updated meta-analysis based on 37 studies. World J Gastroenterol 2016; 22(5): 1911-1918 [PMID: 26855551 DOI: 10.3748/wjg.v22.i5.1911] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
9 Matejcic M, Iqbal Parker M. Gene-environment interactions in esophageal cancer. Crit Rev Clin Lab Sci 2015;52:211-31. [PMID: 26220475 DOI: 10.3109/10408363.2015.1020358] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
10 Ma L, Lan B, Guo L, Nong S, Huang C, Wu Q, Huang Z. GSTM1 and GSTT1 Gene Polymorphisms, Gene-Gene Interaction, and Esophageal Carcinoma Risk: Evidence from an Updated Meta-Analysis. Genetic Testing and Molecular Biomarkers 2018;22:11-9. [DOI: 10.1089/gtmb.2017.0137] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Yang NN, Huang YF, Sun J, Chen Y, Tang ZM, Jiang JF. Meta-analysis of XRCC1 polymorphism and risk of female reproductive system cancer. Oncotarget 2017;8:28455-62. [PMID: 28415705 DOI: 10.18632/oncotarget.16090] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Djansugurova L, Zhunussova G, Khussainova E, Iksan O, Afonin G, Kaidarova D, Parker MI. Association of DCC, MLH1, GSTT1, GSTM1, and TP53 gene polymorphisms with colorectal cancer in Kazakhstan. Tumour Biol. 2015;36:279-289. [PMID: 25249451 DOI: 10.1007/s13277-014-2641-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
13 Hu YY, Zheng R, Guo C, Niu YM. Association between cyclin D1 G870A polymorphism and cervical cancer risk: a cumulative meta-analysis involving 2,864 patients and 3,898 controls. Diagn Pathol 2014;9:168. [PMID: 25204741 DOI: 10.1186/s13000-014-0168-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
14 Pu Y, Zhao L, Dai N, Xu M. Comprehensive analysis of the correlation between base-excision repair gene SNPs and esophageal squamous cell carcinoma risk in a Chinese Han population. Mol Clin Oncol 2020;13:228-36. [PMID: 32714550 DOI: 10.3892/mco.2020.2066] [Reference Citation Analysis]
15 Wu Y, Fu H, Zhang H, Huang H, Chen M, Zhang L, Yang H, Qin D. Cyclin D1 (CCND1) G870A polymorphisms and cervical cancer susceptibility: a meta-analysis based on ten case-control studies. Tumour Biol 2014;35:6913-8. [PMID: 24737585 DOI: 10.1007/s13277-014-1929-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
16 Meng Y, Zhang C, Zhou X. Association between the Cyclin D1 G870A polymorphism and the susceptibility to and prognosis of upper aerodigestive tract squamous cell carcinomas: an updated meta-analysis. Onco Targets Ther 2016;9:367-76. [PMID: 26855585 DOI: 10.2147/OTT.S94635] [Cited by in F6Publishing: 1] [Reference Citation Analysis]